The inexorable rise in the incidence of antibiotic resistance in bacterial pathogens, coupled with the disappointingly low rate of emergence of new,clinically useful antibiotics, has refocused attention on finding alternatives to antibiotic treatments. This event will discuss the potential utility of phages, probiotics, antimicrobial peptides, herbal medicines and immune modulation for treating human and animal disease. This event has CPD accreditation.Who Should Attend
From researchers trying to find alternatives to therapies to pharmacists delivering treatments: any one with an interest in antibiotic alternatives would find this event of value.

The deadline for abstract submissions for oral presentation is August 10th 2014
Abstracts for poster presentation only can be submitted up to two weeks before the event. You can download the instructions for authors at www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf

 Talks include

Enhancing Host Resistance against Lethal Infections.
Professor Roger M. Loria, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA

Anti-microbial cationic peptides as a strategy for innovation in global health therapeutics for human infectious deseases
Dr Hussin Rothan, Researcher, Faculty of Medicine, University of Malaya, Kuala Lumpur , Malaysia

Host-Defense Peptides To New Antimicrobial Agents
Dr. Paul R. Hansen, University of Copenhagen, Denmark

Quorum sensing inhibitors an alternate to conventional antibiotics
Dr. Pragasam Viswanathan, School of Bio Sciences and Technology, VIT University, India

Probiotic bacteria against multiresistant pathogens
Professor Iryna Sorokulova, Auburn University, Auburn, AL, USA

Echinoderms as source of novel antimicrobial peptides to contrast human pathogens
Dr Domenico Schillaci, Lecturer, University of Palermo, Palermo, Italy

Clinical Application of Probiotics in Antibiotic Therapy: the Current and Future Use
Dr Thomas A. Tompkins, Research Director, Lallemand Health Solutions Inc, Montreal, Canada

War against Microbes: are Antibiotics the only Weapons
Dr. Jayanta Haldar, Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore , India

Development of novel polymyxins targeting multi-drug resistant Gram-negative ‘superbugs’
Dr Tony Velkov, Monash Institute of Pharmaceutical Sciences, Victoria, Australia

Antibodies as a limitless source of peptides with innate microbicidal  and immunomodulatory activity
Professor Luciano Polonelli, Full Professor in Microbiology and Clinical Microbiology Unit of Microbiology and Virology Department of Biomedical, Biotechnological and Translational Sciences PARMA, Italy

Antibiotic versus maggot therapy in diabetic foot ulcer
Professor Chumpon Wilasrusmee, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bankok, Thailand